Sensor Cloud Network
Unleashing the Potential
of Human-Data Connections
Medidata Sensor Cloud Network fosters industry-wide collaboration amongst CROs, sensor and connected device manufacturers, sponsors, analytic companies, and academia focused on solving challenges related to sensor integrations, standardization of sensor data, and the development of digital biomarkers and algorithms.
Our Network provides cutting edge tools, technology and training to enable the discovery and delivery of third-party algorithms at scale, leading to new breakthroughs in advancing the understanding of disease progression, which in turn will help to drive the development of more effective treatments for patients.
Why Join the Sensor Cloud Network?
Simplify the integration model and deployment process for digital health technologies by collaborating with developers and innovators on new solutions spanning technologies, content, guidance, and methodologies.
Greater Visibility and Impact
Sensor Cloud Network provides a centralized, secure repository to upload and test code while providing opportunities to evaluate algorithms across a variety of datasets spanning multiple therapeutic areas. Expand your impact and exposure with commercial opportunities via our licensing model for commercial use of exploratory and validated algorithms.
Expertise and Access
Collaborate with industry experts focused on addressing challenges related to the standardization of sensor data and the discovery of digital biomarkers and new digital endpoints. Create new sensor integration models while developing new algorithms to support the generation of real-world evidence through deeper insights and more robust, objective data.
Key Features of Sensor Cloud Network
Develop New Digital Endpoints
Shared data and expertise help to develop greater clinical insights that can deliver new therapies, more effective treatments, and a better experience for patients.
Expanded Access to Data and Analytics
Our platform provides a single, collaborative environment for researchers, data scientists, engineers, and clinicians to work together and share information.
Become part of a connected network that supports the development of deeper insights and a better means of analyzing patient data on a single platform.
Medidata Patient Cloud
Patient Cloud is a suite of digital health solutions designed to collect high-quality data from engaged patients regardless of their location.
Whether your clinical trials are primarily site-based or decentralized, Patient Cloud technologies help create a better overall study experience for patients, sponsors, and sites.
Medidata Sensor Cloud delivers a more complete picture of the patient experience while allowing for greater flexibility throughout clinical trials. Our common model enables rapid ingestion, standardization, and analysis of data from any device resulting in greater clinical insights that can deliver more effective treatments, and ultimately new therapies for patients.
Medidata eCOA provides a flexible, intuitive model for capturing patient data that is designed to make it easier for patients to engage in clinical trials. Built as part of the unified Medidata Clinical Cloud™ platform, Medidata eCOA improves your study experience with flexible deployment options, a groundbreaking global instrument library, and dedicated services and support.
Get to Know Our Sensor Cloud Network Partners
AliveCor provides specialized ECG-based digital health solutions to enable decentralized clinical trials. AliveCor’s KardiaMobile 6L is the world’s first and only FDA-cleared six-lead personal ECG device, more than any other personal ECG, allowing clinical trials to be conducted remotely, without sacrificing data quality.
Aural Analytics strives to improve patient outcomes by unlocking the valuable brain health data available in the speech signal with scientifically sound and technically viable speech analytics technology. The speech analytics technology provides objective, repeatable metrics-unlocking a new paradigm of patient care.
Biobeat’s solution uses health-AI and ML on big-data in order to provide actionable insights on patient care. More than just analyzing the data, BioBeat provides FDA-cleared data generation and analysis on 13 vital signs, all continuously, wirelessly and in real-time. BioBeat’s solution employs either the wrist-monitor or the chest-monitor.
Blue Spark Technologies
Blue Spark Technologies believes that continuous vital sign monitoring is the key to improving the standard of care in hospitals and enhancing data collection capabilities in clinical trials. Blue Spark’s TempTraq® is an FDA 510 (k) and CE cleared class II HIPAA-compliant patient temperature monitoring system that collects and transmits temperature for up to 72 hours.
Indie Health makes remote patient monitoring easy, affordable, scalable, and reliable, by providing a one-stop-shop experience of accessing data from a FDA cleared/CE marked RPM device portfolio consisting of pulse oximeter, thermometer, blood pressure monitor, weight scale, glucometer and activity tracker with heart rate monitor.
Glooko software platforms empower the management of diabetes and related conditions by collecting and unlocking the power of data from blood-glucose meters, CGMs, insulin pumps, connected insulin pens, blood pressure cuffs, nutrition apps, connected scales and activity trackers—bringing insights together in one place.
Developing Your Mobile Sensor Strategy Journey For Better Study Outcomes
Highlights the key considerations and challenges when implementing a digital health technology strategy for clinical trials.
ISR and Medidata: Primary Motivations and Challenges with Sensor Usage in Clinical Trials
View our latest infographic highlighting key challenges and motivations for incorporating connected devices into clinical trials.
The Industry-Standard Data Ingestion and Biomarker Science Backbone for Clinical Studies
Discover the capabilities and benefits of implementing a unified platform to support enhanced insights and the development of new digital biomarkers.
Advancing Decentralized Clinical Trials Through a Unified Approach to eCOA and Digital Health Technologies
Drug developers are increasingly harnessing the combined power of objective data from digital health technologies (DHTs) and subjective clinical outcome assessments that include patient-reported outcomes (PROs).
Uniting these two complementary mechanisms is enabling the development of comprehensive patient profiles that better inform how patients experience their disease and respond to treatment.